According to a new report by UnivDatos, the Premenstrual Syndrome Treatment Market is expected to reach USD million in 2033 by growing at a CAGR of 4.74%. Key Highlights of the Report: Ø The increasing prevalence of premenstrual syndrome (PMS) due to lifestyle changes, elevated stress, poor diet, and hormonal imbalances is driving the global premenstrual syndrome treatment market....